Expression profiling of ETS and MMP factors in VEGF-activated endothelial cells: Role of MMP-10 in VEGF-induced angiogenesis

Journal of Cellular Physiology

Volumn 224, Issue 3, 2010, Pages 734-742

  Heo, Sun Hee ^a   Choi, Young Jin ^a   Ryoo, Hyun Mo ^b   Cho, Je Yoel ^a  

^a Kyungpook National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STROMELYSIN 2; STROMELYSIN 3; TRANSCRIPTION FACTOR ETS; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA INTERFERENCE; UMBILICAL VEIN; UPREGULATION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; MATRIX METALLOPROTEINASE 10; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-ETS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77954216551     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22175     Document Type: Article

References (45)

1. Abid MR, Nadeau RJ, Spokes KC, Minami T, Li D, Shih SC, Aird WC. 2008. Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells. Arterioscler Thromb Vasc Biol 28:2042-2048.
2. Ayadi A, Zheng H, Sobieszczuk P, Buchwalter G, Moerman P, Alitalo K, Wasylyk B. 2001. Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J 20:5139-5152. (Pubitemid 32910909)
3. Barrett JM, Puglia MA, Singh G, Tozer RG. 2002. Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. Breast Cancer Res Treat 72:227-232. (Pubitemid 34430004)
4. Bodey B, Bodey B, Jr., Siegel SE, Kaiser HE. 2000a. Immunocytochemical detection of MMP-3 and -10 expression in hepatocellular carcinomas. Anticancer Res 20:4585-4590. (Pubitemid 32141823)
5. Bodey B, Bodey B, Jr., Siegel SE, Kaiser HE. 2000b. Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors. In Vivo 14:667-673. (Pubitemid 34097529)
6. Bodey B, Bodey B, Jr., Siegel SE, Kaiser HE. 2000c. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas. In Vivo 14:659-666. (Pubitemid 34097528)
7. Bodey B, Bodey B, Jr., Siegel SE, Kaiser HE. 2000d. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts. In Vivo 14:675-682.
8. Buttice G, Duterque-Coquillaud M, Basuyaux JP, Carrere S, Kurkinen M, Stehelin D. 1996. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13:2297-2306. (Pubitemid 27026012)
9. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389-395.
10. Carmeliet P. 2003. Angiogenesis in health and disease. Nat Med 9:653-660.
11. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. 2003. Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 253:269-285.
12. Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN. 2006. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126:321-334. (Pubitemid 44092958)
13. Cheng SM, Xing B, Li JC, Cheung BK, Lau AS. 2007. Interferon-gamma regulation of TNFalpha-induced matrix metalloproteinase 3 expression and migration of human glioma T98G cells. Int J Cancer 121:1190-1196. (Pubitemid 47293784)
14. Crawford HC, Matrisian LM. 1996. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49:20-37.
15. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
16. Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA. 2004. Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J Biol Chem 279:11281-11292. (Pubitemid 38401625)
17. Ha CH, Jhun BS, Kao HY, Jin ZG. 2008. VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis. Arterioscler Thromb Vasc Biol 28:1782-1788.
18. Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M. 1999. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int J Cancer 82:274-281. (Pubitemid 29293788)
19. Hanzawa M, Shindoh M, Higashino F, Yasuda M, Inoue N, Hida K, Ono M, Kohgo T, Nakamura M, Notani K, Fukuda H, Totsuka Y, Yoshida K, Fujinaga K. 2000. Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21:1079-1085.
20. He J, Pan Y, Hu J, Albarracin C, Wu Y, Dai JL. 2007. Profile of Ets gene expression in human breast carcinoma. Cancer Biol Ther 6:76-82. (Pubitemid 46294180)
21. Hida K, Shindoh M, Yasuda M, Hanzawa M, Funaoka K, Kohgo T, Amemiya A, Totsuka Y, Yoshida K, Fujinaga K. 1997. Antisense E1AF transfection restrains oral cancer invasion by reducing matrix metalloproteinase activities. Am J Pathol 150:2125-2132. (Pubitemid 27233083)
22. Higashino F, Yoshida K, Noumi T, Seiki M, Fujinaga K. 1995. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10:1461-1463.
23. Hollenhorst PC, Jones DA, Graves BJ. 2004. Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 32:5693-5702.
24. Jayaraman G, Srinivas R, Duggan C, Ferreira E, Swaminathan S, Somasundaram K, Williams J, Hauser C, Kurkinen M, Dhar R, Weitzman S, Buttice G, Thimmapaya B. 1999. p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter. J Biol Chem 274:17342-17352.
25. Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA, Gunther CV, Nye JA. 1990. The ETS-domain: A new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev 4:1451-1453. (Pubitemid 20310065)
26. Kita D, Takino T, Nakada M, Takahashi T, Yamashita J, Sato H. 2001. Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line. Cancer Res 61:7985-7991. (Pubitemid 33049391)
27. Kobberup S, Nyeng P, Juhl K, Hutton J, Jensen J. 2007. ETS-family genes in pancreatic development. Dev Dyn 236:3100-3110.
28. Nagase H, Woessner JF, Jr. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
29. Nye JA, Petersen JM, Gunther CV, Jonsen MD, Graves BJ. 1992. Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev 6:975-990.
30. Oda N, Abe M, Sato Y. 1999. ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 178:121-132. (Pubitemid 29034855)
31. Orbe J, Rodriguez JA, Calvayrac O, Rodriguez-Calvo R, Rodriguez C, Roncal C, Martinez de Lizarrondo S, Barrenetxe J, Reverter JC, Martinez-Gonzalez J, Paramo JA. 2009. Matrix metalloproteinase-10 is upregulated by thrombin in endothelial cells and increased in patients with enhanced thrombin generation. Arterioscler Thromb Vasc Biol 29:2109-2116.
32. Overall CM, Lopez-Otin C. 2002. Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nat Rev Cancer 2:657-672. (Pubitemid 37328917)
33. O-Charoenrat P, Rhys-Evans PH, Eccles SA. 2001. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127:813-820. (Pubitemid 32619361)
34. Park YH, Jung HH, Ahn JS, Im YH. 2008. Ets-1 upregulates HER2-induced MMP-1 expression in breast cancer cells. Biochem Biophys Res Commun 377:389-394.
35. Rundhaug JE. 2005. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9:267-285.
36. Saghizadeh M, Brown DJ, Castellon R, Chwa M, Huang GH, Ljubimova JY, Rosenberg S, Spirin KS, Stolitenko RB, Adachi W, Kinoshita S, Murphy G, Windsor LJ, Kenney MC, Ljubimov AV. 2001. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: A possible mechanism of basement membrane and integrin alterations. Am J Pathol 158:723-734.
37. Sahin A, Vercamer C, Kaminski A, Fuchs T, Florin A, Hahne JC, Mattot V, Pourtier-Manzanedo A, Pietsch T, Fafeur V, Wernert N. 2009. Dominant-negative inhibition of Ets 1 suppresses tumor growth, invasion and migration in rat C6 glioma cells and reveals differentially expressed Ets 1 target genes. Int J Oncol 34:377-389.
38. Sato Y, Kanno S, Oda N, Abe M, Ito M, Shitara K, Shibuya M. 2000. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann NY Acad Sci 902:201-205, discussion 205-207.
39. Saunders WB, Bayless KJ, Davis GE. 2005. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 118:2325-2340.
40. Sementchenko VI, Watson DK. 2000. Ets target genes: Past, present and future. Oncogene 19:6533-6548.
41. Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK. 2000. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol 20:5643-5652.
42. Wang H, Keiser JA. 1998. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1. Circ Res 83:832-840.
43. Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH. 1997. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J 16:4374-4383.
44. Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, Alt FW, Gilliland DG, Golub TR, Orkin SH. 1998. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev 12:2392-2402.
45. Zhao Y, Zhou S, Heng CK. 2009. Celecoxib inhibits serum amyloid a-induced matrix metalloproteinase-10 expression in human endothelial cells. J Vasc Res 46:64-72.